Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
5.95
+0.02 (0.34%)
Mar 2, 2026, 4:00 PM EST - Market closed
Bausch Health Companies Revenue
In the year 2025, Bausch Health Companies had annual revenue of $10.27B with 6.66% growth. Bausch Health Companies had revenue of $4.90B in the quarter ending December 31, 2025, with 91.53% growth.
Revenue (ttm)
$11.62B
Revenue Growth
+29.49%
P/S Ratio
0.21
Revenue / Employee
$505,714
Employees
20,300
Market Cap
2.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.27B | 641.00M | 6.66% |
| Dec 31, 2024 | 9.63B | 868.00M | 9.91% |
| Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
| Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
| Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
| Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
| Dec 31, 2019 | 8.60B | 221.00M | 2.64% |
| Dec 31, 2018 | 8.38B | -344.00M | -3.94% |
| Dec 31, 2017 | 8.72B | -950.00M | -9.82% |
| Dec 31, 2016 | 9.67B | -773.00M | -7.40% |
| Dec 31, 2015 | 10.45B | 2.24B | 27.31% |
| Dec 31, 2014 | 8.21B | 2.44B | 42.23% |
| Dec 31, 2013 | 5.77B | 2.29B | 65.77% |
| Dec 31, 2012 | 3.48B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Perrigo Company | 4.25B |
| Hims & Hers Health | 2.35B |
| Phibro Animal Health | 1.46B |
| Prestige Consumer Healthcare | 1.10B |
| ANI Pharmaceuticals | 883.37M |
| BioCryst Pharmaceuticals | 874.84M |
| Supernus Pharmaceuticals | 718.95M |
| Kiniksa Pharmaceuticals International, | 677.56M |
BHC News
- 8 days ago - Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada - PRNewsWire
- 11 days ago - Bausch + Lomb Q4 Earnings Review: Still A Buy, With Some Caveats - Seeking Alpha
- 11 days ago - How Bausch Health's Turnaround Progressed In Q4 2025 - Seeking Alpha
- 12 days ago - Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres - PRNewsWire
- 12 days ago - Bausch Health Companies Inc. (BHC) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS - PRNewsWire
- 14 days ago - Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference - PRNewsWire
- 20 days ago - Bausch Health Announces 2026 Gastrointestinal Health Scholars Program - PRNewsWire